A Cost Effectiveness Analysis (CEA) of Phenytoin (PHT) Versus Levetiracetam (LEV) for Early Seizure Pharmacoprophylaxis after Traumatic Brain Injury (TBI) from A US Institutional Perspective- An Upgrade of a Cost Minimization Analysis (CMA) ...
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1402
https://www.valueinhealthjournal.com/article/S1098-3015(18)31708-X/fulltext
Title :
A Cost Effectiveness Analysis (CEA) of Phenytoin (PHT) Versus Levetiracetam (LEV) for Early Seizure Pharmacoprophylaxis after Traumatic Brain Injury (TBI) from A US Institutional Perspective- An Upgrade of a Cost Minimization Analysis (CMA) ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31708-X&doi=10.1016/j.jval.2018.04.1402
First page :
Section Title :
Open access? :
No
Section Order :
647